Go to the list of all blogs
Sarah Patel's Avatar
published in Blogs
Dec 29, 2022

Alzamend Neuro (ALZN, $0.51) partners with Stem Cell Institute at the University of Miami for trial of ALZN002

Alzamend Neuro Inc .has partnered with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase 1/2A trial of ALZN002.

ALZN002 is a patented immunotherapy method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to combat Alzheimer’s. On October 5, Alzamend announced the addition of healthy adult subject to its Phase IIA multiple ascending dose (“MAD”) study of AL001 in subjects with dementia related to Alzheimer’s.

“We are thrilled to add the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami to the team and have full confidence in their ability to assist us with our Phase I/IIA clinical trial of ALZN002,” stated Stephan Jackman, Chief Executive Officer of Alzamend. “We strongly believe that the ALZN002 patient-specific immunotherapeutic vaccine has the potential of fostering tolerance to treatment for safety purposes while stimulating the immune system to reduce the brain’s beta-amyloid protein burden, resulting in reduced Alzheimer’s signs and symptoms. We are advancing the process and expect to initiate this study in the first quarter of 2023.”

“We look forward to reporting topline data from the Phase IIA MAD study in the second quarter of 2023,” mentioned Mr. Jackman. “We are one step closer to providing patients, caregivers and clinicians with a major improvement over current lithium-based treatments that can help over 40 million Americans suffering from Alzheimer’s, bipolar disorder, MDD and PTSD. We look forward to completing the Phase IIA MAD study and further advancing clinical development of this promising potential therapeutic.”

Related Ticker: ALZN

ALZN in upward trend: price rose above 50-day moving average on February 28, 2024

ALZN moved above its 50-day moving average on February 28, 2024 date and that indicates a change from a downward trend to an upward trend. In of 21 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 28, 2024. You may want to consider a long position or call options on ALZN as a result. In of 42 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for ALZN crossed bullishly above the 50-day moving average on March 04, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALZN advanced for three days, in of 113 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALZN broke above its upper Bollinger Band on March 04, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.353) is normal, around the industry mean (28.923). P/E Ratio (0.000) is within average values for comparable stocks, (125.960). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.190). Dividend Yield (0.000) settles around the average of (0.031) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.695).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ALZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.61B. The market cap for tickers in the group ranges from 402 to 552.32B. NVO holds the highest valuation in this group at 552.32B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 4%. For the same Industry, the average monthly price growth was 19%, and the average quarterly price growth was 54%. BMNDF experienced the highest price growth at 241%, while NERV experienced the biggest fall at -62%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 34%. For the same stocks of the Industry, the average monthly volume growth was 104% and the average quarterly volume growth was 63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 52
SMR Rating: 94
Profit Risk Rating: 93
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
ALZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TELL0.820.05
+7.10%
Tellurian
OUT15.360.58
+3.92%
OUTFRONT Media
BTCT3.700.05
+1.37%
BTC Digital Ltd
JNPR37.640.27
+0.72%
Juniper Networks
GTH3.91-0.01
-0.26%
Genetron Holdings Limited

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SNSE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+5.50%
SNSE - ALZN
41%
Loosely correlated
+11.18%
SPRC - ALZN
31%
Poorly correlated
-4.03%
AXON - ALZN
30%
Poorly correlated
+1.76%
MDGL - ALZN
29%
Poorly correlated
-2.07%
AVRO - ALZN
29%
Poorly correlated
-1.88%
More
Ad is loading...
The Thermals group has shown remarkable resilience and growth, with a remarkable performance increase of +4.57% over the last month. Comprising tickers such as DAN, INTT, BRKR, WAT, and PNR, this group is at the forefront of thermal analysis and related technologies. In this article, we delve into the performance of these stocks, explore their market capitalization, price trends, and highlight specific insights for three key tickers: DAN, INTT, and PNR.
This week, the market has shown a promising turnaround and is likely to continue its growth. Industrial Machinery stocks have performed well, with some seeing gains of 3-5% over the past week. You can check out signals for these companies' stocks in our robot: Swing-Trader-1-5K-per-position-Medium-Volatility-Stocks-for-Active-Trading-TA-FA.
The pharmaceuticals generic industry is a significant player in the global drug market. Generic drugs, which contain the same chemical substance as their patented counterparts, are sold at more affordable prices once the patents for the original drugs expire. This affordability has led to the vast popularity of generic drugs.
#artificial_intelligence
One notable example is the "Day Trader: Medium Volatility Stocks for Active Trading (TA&FA)" bot, which has demonstrated its prowess as more than just a trading tool – it's a bot factory generating remarkable gains. Over the previous week, this AI trading bot managed to achieve a remarkable +8.37% gain by actively trading NVDA, a clear testament to the potential of combining technical and fundamental analysis with automated trading strategies.
The Tobacco industry has demonstrated a remarkable upswing in its performance over the past week, with a significant increase of +4.31%. This positive momentum is reflected across a group of prominent tickers within the industry, including XXII, GNLN, RLX, KAVL, and HPCO.
Dive into the fascinating world of nuclear energy as we uncover the remarkable gains achieved by top performers in the industry. Stocks like $HII, $BWXT, $PESI, $LTBR, and $WVE have surged by an impressive +14.14%. Discover the driving forces behind these remarkable market movements and the potential opportunities they unveil. Don't miss out on the insights that could reshape your investment strategy!
#latest#popular#artificial_intelligence#trading#technical_analysis#asset_allocation
Thermo Fisher Scientific ($TMO) emerges as a beacon of hope for investors, registering a remarkable 5.38% jump this week. Dive in to discover what's fueling TMO's impressive ascent in the Medical Specialties sector. 🚀📈
#latest#popular#artificial_intelligence#trading#neutral_bluish
Automation has seamlessly integrated into various facets of our daily lives. From simplifying money transfers to revolutionizing industrial operations and enhancing security services, the scope of automation is vast and ever-expanding.
#artificial_intelligence
One prominent player in this arena is the "Swing trader: Long-Short Equity Strategy (TA&FA)" bot, which recently demonstrated its prowess by achieving an impressive +5.12% gain while trading MRNA over the past week. This article delves into the latest earnings report, market trends, and the role of AI-driven trading in navigating these waters.
The Other Transportation industry has witnessed a remarkable surge of +11.1% in its performance over the past week, catching the attention of investors and analysts alike. This article delves into the exciting developments within this industry, with a specific focus on two key tickers: ASLE and UP.
This week, the market is showing significant growth, especially in the semiconductor sector, where company stocks are rising by 5-7%. Our robots have actively participated in this and achieved some good results. If you want to receive instant signals for successful trades, subscribe to one of our robots at the following link:Swing-Trader-1-5K-per-position-Medium-Volatility-Stocks-for-Active-Trading-TA-FA Let's earn together on the market's upward trend!
These AI trading robots, accessible at "Swing trader: Downtrend Protection (TA)," have proven their mettle by delivering a remarkable +4.72% gain while trading TSLA over the course of the previous week. In this article, we delve into the recent performance of TSLA, analyzing its earnings results, market capitalization, price trends, and trading volume to provide valuable insights for investors.
Discover how the shale oil sector is making waves, with impressive gains of +5.24%. Dive into the market movements of key players like $XOM, $BHP, $EOG, $PXD, and $HES, as we uncover the dynamics driving this surge in the energy industry. Explore the latest trends, price shifts, and indicators that could shape the future of shale oil investments.
In a week dominated by bullish sentiment, Alphabet (GOOG) emerges triumphant, registering an impressive +5.28% rise. Dive into the factors propelling this tech titan's stock performance and what it might signal for the future." 🌐💹🚀
#popular#latest#artificial_intelligence#neutral_bluish#trading#technical_analysis#asset_allocation
The Homebuilding industry has experienced a significant increase of +8.85% in its performance over the past week. This surge in performance has not only captured the attention of investors but has also sparked optimism for the future of the sector. In this article, we'll delve into the theme of the Homebuilding industry, examine the group of tickers within it, and highlight some notable developments.
In the ever-evolving world of trading, AI trading robots are becoming increasingly popular due to their ability to analyze vast amounts of data and make quick, data-driven decisions. One such AI trading robot, known as "Swing trader: Deep Trend Analysis v.2 (TA)," recently made headlines with an impressive +4.35% gain while trading FUBO over the course of the previous week. In this article, we'll delve into the technical analysis of FUBO's recent performance, earnings results, and broader market trends.
One such industry that has recently caught the attention of financial analysts is the Office Equipment/Supplies Industry. In the past week, this industry has displayed remarkable performance, with a notable increase of +5.46%. Let's delve into the theme and the group of tickers within it to better understand this surge.
Discover the Power of Tech Peripherals: Join us as we delve into the recent +7.48% gain by top tickers $HPQ, $SMCI, $ALOT, $INVE, $SSYS. Uncover market insights and potential opportunities in the computer peripherals sector. 📈💼 #TechPeripherals #StockMarket"
#trading#latest#popular#artificial_intelligence#neutral_bluish#asset_allocation
Lululemon Athletica's recent surge is making headlines, with a notable +11.00% uptick. Dive into the numbers, trends, and predictions surrounding LULU's performance, and discover where the stock might be headed next. 📈👕🚀
#latest#popular#artificial_intelligence#neutral_bluish#trading#asset_allocation
Join the ranks of smart traders who have already experienced the benefits of Tickeron's robust algorithm. Don't let market uncertainty hold you back any longer – take control of your financial future with a strategy that can withstand the test of time.